Myriad GmbH has been party to eight Unified Patent Court cases, 3 times as claimant and 5 times as respondent. The most recent on record is UPC CoA 32/2026 at the Court of Appeal, brought by GXD-Bio Corporation. Its most recent decision on the merits was in UPC CFI 437/2024 at the Munich Local Division on 19 December 2025: no infringement found.
- 2026-02-19UPC CoA 32/2026Court of Appeal—GXD-Bio Corporation v Eurobio Scientific GmbH
- 2026-02-19UPC CoA 33/2026Court of Appeal—GXD-Bio Corporation v Eurobio Scientific GmbH
- 2026-01-19UPC CFI 192/2026Munich LD—Myriad International GmbH v GXD-Bio Corporation
- 2026-01-19UPC CFI 195/2026Munich LDCosts onlyMyriad Genetics S.A.S. v GXD-Bio Corporation
- 2024-11-08UPC CFI 681/2024Munich LDPatent revokedMyriad Genetics S.A.S. v GXD-Bio Corporation
- 2024-07-25UPC CFI 437/2024Munich LDNo infringementGXD-Bio Corporation v Myriad International GmbH
- —UPC APP 51844/2024Munich LDClaim dismissedGXD-Bio Corporation v Myriad International GmbH
- —UPC APP 59539/2024Munich LDProcedural onlyGXD-Bio Corporation v Myriad International GmbH